ATM deficiency and oxidative stress: A new dimension of defective response to DNA damage

DNA Repair

Volumn 1, Issue 1, 2002, Pages 3-25

  Barzilai, Ari ^a   Rotman, Galit ^a   Shiloh, Yosef ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Ataxia telangiectasia; ATM; DNA double strand breaks; Oxidative stress; Reactive oxygen species

Indexed keywords

ATM PROTEIN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; NITRIC OXIDE; NITRITE; OXYGEN; PEROXY RADICAL; PROTEIN KINASE C INHIBITOR; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

AEROBIC METABOLISM; ATAXIA TELANGIECTASIA; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; DEFENSE MECHANISM; DNA DAMAGE; DNA STRAND BREAKAGE; DOPAMINE METABOLISM; ENZYME ACTIVITY; GENETIC DISORDER; GENETIC STABILITY; HUMAN; IMMUNE DEFICIENCY; LIPID PEROXIDATION; NERVE CELL DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PHENOTYPE; PREMATURE AGING; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY; ANIMAL; CHROMOSOME BREAKAGE; GENETIC RECOMBINATION; GENETICS;

ANIMAL; ATAXIA TELANGIECTASIA; CHROMOSOME BREAKAGE; DNA DAMAGE; HUMAN; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; RECOMBINATION, GENETIC; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; HUMANS; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0036012789     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-7864(01)00007-6     Document Type: Review

References (203)

1. Genetic disorders associated with cancer predisposition and genomic instability
2. Genome maintenance mechanisms for preventing cancer
3. ATM and ATR: Networking cellular responses to DNA damage
4. ATM: Genomic stability, neuronal development and cancer cross paths
5. Cell cycle checkpoint signaling through the ATM and ATR kinases
6. The genetic defect in ataxia-telangiectasia
7. Ataxia-telangiectasia
8. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene
9. DNA-PK, ATM and ATR as sensors of DNA damage: Variations on a theme?
10. Nuclear retention of ATM at sites of DNA double strand breaks
11. Splitting the ATM: Distinct repair and checkpoint defects in ataxia-telangiectasia
12. The ATM gene and protein: Possible roles in genome surveillance, checkpoint controls and cellular defense against oxidative stress
13. Ataxia-telangiectasia: Is ATM a sensor of oxidative damage and stress?
14. Oxidative stress is a major contribution to aging
15. Breakage of chromosomes by oxygen
16. Free radicals as mediators of tissue injury and disease
17. Biological origin of free radicals, and mechanisms of antioxidant protection
18. Oxidative DNA damage: Endogenous and chemically induced
19. Reactive oxygen species in cell signaling
20. Antioxidants, DNA damage and gene expression
21. Do mitochondria produce oxygen free radicals in vivo?
22. Mitochondria generate superoxide anion radicals and hydrogen peroxide
23. Superoxide radical and hydrogen peroxide in mitochondria
24. The NADPH oxidase of endothelial cells
25. Redox regulation of cellular syndrome
26. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro
27. Role of free radicals and catalytic metal ions in human disease: A review
28. EPR spin trapping study on the oxidizing species formed in the reaction of the ferrous ion with hydrogen peroxide
29. Aging is a specific biological function rather than the result of a disorder in complex living systems: Biochemical evidence in support of Weisman's hypothesis
30. Calculations of hydroxyl radical attack on different forms of DNA
31. Nitric oxide release accounts for the biological activity of endothelium releasing factor
32. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide
33. Kinetics of superoxide dismutase - An iron catalyzed nitration of phenolics by peroxynitrite
34. Peroxynitrite induced membrane lipid peroxidation. The cytotoxic potential of superoxide and nitric oxide
35. Inactivation of alpha-1-proteinase inhibitor by peroxynitrite
36. A stable solid that generates hydroxyl radical upon dissolution in aqueous solution: Reaction with proteins and nucleic acids
37. Inhibition of mitochondrial electron transport by peroxynitrite
38. Peroxynitrite causes calcium efflux from mitochondria which is prevented by cyclosporin A
39. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?
40. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase
41. Formation and biological reactivity of lipid peroxidation products
42. Oxidative stress, antioxidant defense, and damage removal, repair, and replacement systems
43. Antioxidant enzymes and their implications in pathophysiologic processes
44. Markers of oxidative damage and antioxidant protection: Current status and relevance to disease
45. Measurement of cellular repair activities for oxidative DNA damage
46. Antioxidants and protein oxidation
47. Oxidation of methionine in proteins: Roles in antioxidant defense and cellular regulation
48. Oxidative base damage to DNA: Specificity and base excision repair enzymes
49. Repair of oxidative DNA damage - An important factor reducing cancer risk. Minireview
50. Base excision repair in nuclear and mitochondrial DNA
51. Glutathione S-transferase: Genetics and role in toxicology
52. Thioredoxin and glutredoxin systems
53. Thioltrasferases
54. Mammalian Ogg1/Mmh gene plays a major role in repair of the 8-hydroxyguanine lesion in DNA
55. BRCA1and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells
56. P53 Interacts with the DNA mismatch repair system to modulate the cytotoxicity and mutagenicity of hydrogen peroxide
57. Silent repair accounts for cell cycle specificity in the signaling of oxidative DNA lesions
58. Oxidative stress and cell cycle checkpoint function
59. Linking DNA damage and neurodegeneration
60. Ataxia telangiectasia mutated is essential during adult neurogenesis
61. NMDA receptors activate the arachidonic acid cascade system in striatal neurons
62. Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus
63. Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease?
64. Free radicals in disease
65. The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease
66. Parkinson's disease as a multifactorial oxidative neurodegeneration: Implications for integrative management
67. Oxidative alterations in Alzheimer's diseases
68. Prospects for new restorative and neuroprotective treatments in Parkinson's disease
69. Lipid peroxidation as a cause of nigral cell death in Parkinson's disease
70. Oxidative stress in Parkinson's disease and other neurodegenerative disorders
71. Free radicals lipid peroxidation and Parkinson's disease
72. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
73. Decrease ferritin in brain of Parkinson's disease
74. Basan lipid peroxidation in substantia nigra is increased in Parkinson's disease
75. Iron and ferritin in substantia nigra in Parkinson's disease
76. Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice
77. Etiology and pathogenesis of Parkinson's disease
78. Pharmacological management of Alzheimer's disease. II. Antioxidant, antihypersensitive and Ergoloid derivatives
79. Superoxide dismutase activity in Alzheimer's disease: Possible mechanism for paird helical formation
80. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: A chronic oxidative paradigm for testing antioxidant therapies in vivo
81. Oxygen-free radicals and amyloidosis in Alzheimer's disease: Is there a connection?
82. Are reactive oxygen species involved in Alzheimer's disease?
83. Direct evidence of oxidative injury produced by the Alzheimer's beta amyloid peptide (1-40) in cultured hippocampal neurons
84. β-Amyloid-induced toxicity in rat hippocampal cells: In vitro evidence for the involvement of free radicals
85. The precursor of Alzheimer's disease A4 protein resembles a cell-surface receptor
86. β-Amyloid peptide free radical fragments initiate lipoperoxidation in a sequence specific fashion: Implications to Alzheimer's disease
87. Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation
88. Oxidative damage in Alzheimer's disease: The metabolic dimension
89. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease
90. Hereditary and acquired motor neurons disease
91. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
92. Amyotrophic lateral sclerosis and syndrome defects in Cu/Zn superoxide dismutase
93. Superoxide dismutase and ALS
94. Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation
95. Amytrophic lateral sclerosis: Recent advances in understanding disease mechanisms
96. Copper/zinc superoxide dismutase mRNA levels are increased in sporadic amytrophic lateral sclerosis motoneurons
97. Copper/zinc superoxide dismutase catalyzes hydroxyl radical production from hydrogen peroxide
98. Enzyme function of copper/zinc superoxide dismutase as a free radical generator
99. A gain-of-function of an amytrophic lateral sclerosis associated Cu/Zn superoxide dismutase mutant: An enhancement of free radical formation due to decrease in Km for hydrogen peroxide
100. Altered reactivity of superoxide dismutase in familial amytrophic lateral sclerosis
101. A familial amytrophic lateral sclerosis-associated A4V Cu/Zn superoxide dismutase has a lower Km for hydrogen peroxide
102. Neuropathologic classification of Huntington disease
103. Neuronal cell death in Huntington's disease: A potential role for dopamine
104. Oxidative stress induced-neurodegenerative diseases: The need for antioxidants that penetrate the blood brain barrier
105. Oxidative injury and potential use of antioxidants in schizophrenia, Prostaglandins leukot
106. Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications
107. Oxidative stress and antioxidants in epilepsy
108. Prions
109. Prion disease: A loss of antioxidant function?
110. Normal prion protein has an activity like that of superoxide dismutase
111. Secondary cartnitine deficiency and impaired docosahexaenoic (22:6n-3) acid synthesis: A common denominator in the pathophysiology of diseases of oxidative phosphorylation and oxidation
112. Mitochondrial abnormalities in CLN2 and CLN3 forms of Batten disease
113. Review of oxidative stress in brain and spinal cord injury: Suggestions for pharmacological and nutritional management strategies
114. Free radical pathways in CNS injury
115. Aging: A theory based on free radical and radiation chemistry
116. The biochemistry of aging
117. Oxidative biochemical markers: Clues to understanding aging in long-lived species
118. Nutrition, oxidative damage, telomere shortening, and cellular senescence: Individual or connected agents of aging?
119. Oxidative damage to mitochondria and aging
120. Extension of lifespan with superoxide dismutase/catalase mimetics
121. The flux of free radical attack through mitochondrial DNA is related to aging rate
122. Mitochondrial DNA deletion mutations colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting, and oxidative damage sarcopenia
123. Mitochondrial DNA mutations, oxidative stress and aging
124. Invited review: Manganese superoxide dismutase in disease
125. Does oxidative damage to DNA increase with age?
126. Oxidative stress and protein aggregation during biological aging
127. Low oxygen concentration extends the lifespan of human diploid cells
128. Mild hypoxia shortens telomers and inhibits proliferation on fibroblasts: A model for senescence?
129. Colony forming ability of ataxia-telangiectasia skin fibroblasts is an indicator of their early senescence and increased demand for growth factors
130. Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells
131. Accelerated telomere shortening in ataxia-telangiectasia
132. Reduced telomere length in ataxia-telangiectasia fibroblasts
133. Critical telomere shortening regulated by the ataxia-telangiectasia gene acts as a DNA damage signal leading to activation of p53 protein and limited life-span of human diploid fibroblasts. A review
134. Age-associated changes of superoxide dismutase and catalase activities in the rat brain
135. Increased oxidative stress in ataxia-telangiectasia evidenced by alterations in redox state of brains from Atm deficient mice
136. Xeroderma pigmentosum and related disorders: Defects in DNA repair and transcription
137. Nucleotide excision repair and human syndromes
138. DNA helicase deficiencies associated with cancer predisposition and premature aging disorders
139. The emerging genetic and molecular basis of Fanconi anaemia
140. Molecular and biochemical aspects of Bloom's syndrome
141. The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage
142. Cognital disorders sharing oxidative stress and cancer proneness as phenotypic hallmark: Prospects for joint research in pharmacology
143. Increased formation of 8-hydrodeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia due to possible catalase deficiency
144. Deficiency in the catalase activity of xeroderma pigmentosum cell and simian virus 40-transformed human cell extracts
145. Retroviral-mediated correction of DNA repair defect in xeroderma pigmentosum cells is associated with recovery of catalase activity
146. Low catalase activity in xeroderma pigmentosum fibroblasts and SV40-transformed human cell lines is directly related to decreased intracellular levels of the cofactor, NADPH
147. Involvement of the Fanconi's anemia protein FA-C in repair processes of oxidative DNA damage
148. Ataxia telangiectasia with a 32 year survival. A clinopathological report
149. Response of fibroblast cultures from ataxia-telangiectasia patients to oxidative stress
150. Response of fibroblast cultures from ataxia-telangiectasia patients to reactive oxygen species generated during inflammatory reactions
151. Hypersensitivity of ataxia telangiectasia fibroblasts to a nitric oxide donor
152. Anti-oxidative capacity in patients with ataxia-telangiectasia
153. Atm-deficient mice: A paradigm of ataxia telangiectasia
154. Dual roles of ATM in the cellular response to radiation and in cell growth control
155. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice
156. Abnormal development of purkinje cells and lymphocytes in Atm mutant mice
157. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs
158. Nitric oxide: A neuronal messenger
159. Free radicals in disease
160. Nitric oxide and cell death
161. Reversal of HO-1 related cytoprotection with increased expression due to reactive iron
162. Superoxide stress identifies neurons at-risk in a model of ataxia-telangiectasia
163. Impaired glutathione biosynthesis in cultured human ataxia telangiectasia cells
164. Adult T cell leukemia-derived factor/human thioredoxin protects syndrome l F-2 cell injury caused by activated neutrophils or hydrogen peroxide
165. Oxidative stress induces adult T cell leukemia derived factor/thioredoxin in the rat retina
166. Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells
167. Oxygen free radicals mediate the induction of manganese superoxide dismutase gene expression by TNF-alpha
168. Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn superoxide dismutase: Implications in Down syndrome
169. Oxidative stress mediates impairment of muscle function in transgenic mice with elevated levels of wild-type Cu/Zn superoxide dismutase
170. Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic Cu/Zn superoxide dismutase neurons
171. Elevated Cu/Zn-SOD exacerbates radiation sensitivity and hematopoietic abnormalities of Atm-deficient mice
172. Protective roles for ATM in cellular response to oxidative stress
173. The chicken B cell line DT40: A novel tool for gene disruption experiments
174. Disruption of ATM in p53-null cells causes multiple functional abnormalities in cellular response to ionizing radiation
175. Spontaneous and oxidative stress-induced programmed cell death in lymphocytes from patients with ataxia telangiectasia (AT)
176. Deregulated apoptosis in ataxia telangiectasia: Association with clinical stigmata and radiosensitivity
177. ATM protein is required for radiation-induced apoptosis and acts before mitochondrial collapse
178. Apoptotic response and cell cycle transition in ataxia telangiectasia cells exposed to oxidative stress
179. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system
180. ATM dependent apoptosis in the nervous system
181. Spontaneously immortalized cell lines obtained from adult Atm cull mice retain sensitivity to ionizing radiation and exhibit a mutational pattern suggestive of oxidative stress
182. A novel signature mutation for oxidative damage resembles a mutational pattern found commonly in human cancers
183. Ataxia-telangiectasia: chronic activation of damage-responsive functions is reduced by alpha-lipoic acid
184. The induction of apoptosis in proliferating human fibroblasts by oxygen radicals is associated with a p53- and p21WAF1CIP1 induction
185. Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles
186. Dual roles of ATM in the cellular response to radiation and in cell growth control
187. Genetic interactions between Atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints
188. The ataxia telangiectasia gene product is required for oxidative stress-induced G1 and G2 checkpoint function in human fibroblasts
189. Role of redox potential and reactive oxygen species in stress signaling
190. 2
191. Expression of the ataxia telagiectasia gene (ATM) product in human cerebellar neurons during development
192. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation
193. Localization of a portion of extranuclear ATM to peroxisome
194. ATM: Expanding roles in the DNA damage response and cellular homeostasis
195. Function of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death
196. Poly(ADP-ribose) polymerase activity is not affected in ataxia telangiectasia cell and knockout mice
197. Enzymatic activities of Sir2 and chromatin silencing
198. NAD(P)H, a directly operating antioxidant?
199. New function of a long-known molecule, emerging roles of NAD in cellular signaling
200. Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide
201. Neuroprotection by the metabolic antioxidant alpha-lipoic acid
202. Antioxidants in nutrition
203. Dietary antioxidants and assessment of oxidative stress